Skip to content

Dyne Therapeutics, Inc. DYN Operating Lease Liabilities (Current)

Operating Lease Liabilities (Current) at other companies

Arrowhead Research logo
Arrowhead ResearchARWR
$7.77M+14.6%
Edgewise Therapeutics, Inc. logo
Edgewise Therapeutics, Inc.EWTX
$1.02M+1.6%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$12.08M+5.4%
Scholar Rock logo
Scholar RockSRRK
$6.08M+10.5%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$446K+8.8%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$1.47M-2.3%

Other financials

Income statement

See full
Operating income-$125.3M-2.4%
Net income-$120.9M-4.8%
EPS (diluted)-$0.73+30.5%

Balance sheet

See full
Cash & equivalents$753.1M+59.5%
Total debt$168.7M+623%
Total equity$865.1M+29.3%
Total assets$1.1B+49.8%

Cash flow

See full
Operating cash flow-$144.9M-36.9%
CapEx$221.0K-77.5%
Free cash flow-$145.1M-35.8%

Valuation

See full
Market cap$3.35B+153%

Returns & leverage

See full
Return on equity-58.9%-4.4pp
Debt / equity0.2×+0.2×
Current ratio19.9×-0.4×

Where this comes from

Reported directly by Dyne Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.

The official record: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dyne Therapeutics, Inc.'s operating lease liabilities (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Dyne Therapeutics, Inc.'s operating lease liabilities (current)?
Dyne Therapeutics, Inc. (DYN) reported operating lease liabilities (current) of $5.03M in Q1 2026.
How has Dyne Therapeutics, Inc.'s operating lease liabilities (current) changed year-over-year?
Dyne Therapeutics, Inc.'s operating lease liabilities (current) decreased by 1.5% year-over-year, from $5.11M to $5.03M.
What does operating lease liabilities (current) mean?
The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.